SC 13D/A

AMENDMENT NO.16 TO SCHEDULE 13D

Company: Lineage Cell Therapeutics, Inc.
Filed: December 28, 2005
Accession Number: 0000950149-05-000818

View Document ↗ View on SEC.gov ↗